Literature DB >> 20233495

Risk factors associated with observed clinical lumpy skin disease in Ethiopia.

G Gari1, A Waret-Szkuta, V Grosbois, P Jacquiet, F Roger.   

Abstract

A cross-sectional study based on a questionnaire survey was conducted to determine the distribution of lumpy skin disease (LSD) and associated risk factors in three main agro-climatic zones of Ethiopia. A total of 330 questionnaire surveys were collected from 44 peasant associations (PA) distributed in 15 districts. Across agro-climate zones, herd-level LSD prevalence in the midland agro-climate was significantly higher 55.2% [95% confidence interval (CI) 47.5-62.6] than in highland and lowland agro-climate zones. Overall observed LSD prevalence at animal-level was 8.1% (95% CI 7.3-8.9) and observed mortality was 2.12% (95% CI 1.73-2.6). The odds ratio (OR) of LSD occurrence in midland vs. highland and lowland vs. highland zones was 3.86 (95% CI 2.61-5.11) and 4.85 (95% CI 2.59-7.1), respectively. Significantly high risk of LSD occurrence was associated with communal grazing and watering management (OR 4.1, 95% CI 2.02-6.18) and introduction of new cattle (OR 8.5, 95% CI 6.0-11.0). Our findings describe the distribution of LSD in different agro-climates in Ethiopia along with associated risk factors, and can help shed light on the epidemiology of LSD in other African countries suffering from the disease.

Entities:  

Mesh:

Year:  2010        PMID: 20233495     DOI: 10.1017/S0950268810000506

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  23 in total

1.  Long-term changes in the spatial distribution of lumpy skin disease hotspots in Zimbabwe.

Authors:  Samuel Swiswa; Mhosisi Masocha; Davies M Pfukenyi; Solomon Dhliwayo; Silvester M Chikerema
Journal:  Trop Anim Health Prod       Date:  2016-10-26       Impact factor: 1.559

2.  Risk assessments of lumpy skin diseases in Borena bull market chain and its implication for livelihoods and international trade.

Authors:  Gezahegn Alemayehu; Girma Zewde; Berhanu Admassu
Journal:  Trop Anim Health Prod       Date:  2012-12-29       Impact factor: 1.559

3.  Seroprevalence and Associated Risk Factors of Lumpy Skin Disease of Cattle in Selected Districts of Afar Region, Ethiopia.

Authors:  Teshager Dubie; Fentaw Hussen Abegaz; Beyene Dereje; Wossene Negash; Muhammed Hamid
Journal:  Vet Med (Auckl)       Date:  2022-08-16

Review 4.  Lumpy skin disease, an emerging transboundary viral disease: A review.

Authors:  Fatemeh Namazi; Azizollah Khodakaram Tafti
Journal:  Vet Med Sci       Date:  2021-02-01

5.  Sero-prevalence of lumpy skin disease in selected districts of West Wollega zone, Ethiopia.

Authors:  Zelalem Abera; Hailu Degefu; Getachew Gari; Menbere Kidane
Journal:  BMC Vet Res       Date:  2015-06-17       Impact factor: 2.741

6.  Mechanical transmission of lumpy skin disease virus by Rhipicephalus appendiculatus male ticks.

Authors:  E S M Tuppurainen; J C Lubinga; W H Stoltsz; M Troskie; S T Carpenter; J A W Coetzer; E H Venter; C A L Oura
Journal:  Epidemiol Infect       Date:  2012-04-30       Impact factor: 4.434

7.  Incidence and molecular characterisation of lumpy skin disease virus in Zimbabwe using the P32 gene.

Authors:  Prettimore Mafirakureva; Bamusi Saidi; Joshua Mbanga
Journal:  Trop Anim Health Prod       Date:  2016-09-26       Impact factor: 1.893

8.  Spatial and Temporal Epidemiology of Lumpy Skin Disease in the Middle East, 2012-2015.

Authors:  Mohammad A Alkhamis; Kimberly VanderWaal
Journal:  Front Vet Sci       Date:  2016-03-03

9.  Temporal and spatial distribution of lumpy skin disease outbreaks in Ethiopia in the period 2000 to 2015.

Authors:  W Molla; M C M de Jong; K Frankena
Journal:  BMC Vet Res       Date:  2017-11-06       Impact factor: 2.741

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.